Clinical Trial Update: Interferon ß-1b Treatment by Cyclical Administration [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating cyclical interferon β-1b treatment for multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Interferon beta-1b (Interferon beta-1b)

Snippet

Sponsor: S. Andrea Hospital | Conditions: Multiple Sclerosis | Phase 2, Phase 3 | Status: COMPLETED